 |
EpiCept Corporation and Immune Pharmaceuticals Amend Merger Agreement
Feb 12, 2013
|
18.5 KB |
|
| |
IMMUNE TO PROVIDE EPICEPT WITH UP TO $0.5 MILLION IN WORKING CAPITAL
HERZLIYA-PITUACH, Israel & TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
Immune Pharmaceuticals Ltd. ("Immune"), a privately held Israeli
company, and EpiCept Corporation (Nasdaq OMX Stockholm Exchange...
|
|
Daniel Teper of Immune Pharmaceuticals to Present at the 6th Annual OneMedForum
Jan 9, 2013
|
12.8 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
announced today that Daniel Teper, Chief Executive Officer of Immune
Pharmaceuticals presented at the 6th Annual OneMedForum, on
Wednesday, January 9, 2013 at 1:40 P...
|
|
EpiCept Reports Third Quarter 2012 Operating and Financial Results
Nov 14, 2012
|
36.8 KB |
|
| |
Conference Call Begins at 9:00 A.M. Eastern Time Today
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) (the
Company) today reported a net loss for the three months ended September
30, 2012 of $1....
|
|
EpiCept to Report Third Quarter 2012 Operating and Financial Results on November 14, 2012
Nov 12, 2012
|
13.0 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
announced today that it will host a conference call on Wednesday,
November 14, 2012 at 9:00 a.m. Eastern time to discuss recent events and
the third quarter 2012 operati...
|
|
Immune Pharmaceuticals and EpiCept Corporation Agree to Merge
Nov 8, 2012
|
17.8 KB |
|
| |
HERZLIYA-PITUACH, Israel & TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
Immune Pharmaceuticals Ltd. ("Immune"), a privately held Israeli
company, and EpiCept Corporation ("EpiCept") (NASDAQ OMX Stockholm
Exchange and OTCQX: EPCT) today announced that they have entered into a
defini...
|
|
EpiCept Corporation Receives One-Month Extension to Loan and Security Agreement
Oct 19, 2012
|
12.4 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
announced today that MidCap Financial, LLC ("MidCap" or the "Lender"),
pursuant to the amendment to the Loan and Security Agreement dated
August 27, 2012, has agreed to ...
|
|
EpiCept Corporation Raises $0.8 Million from Immediate Exercise of Re-priced Warrants
Sep 25, 2012
|
12.8 KB |
|
| |
Series A and B Preferred Stock Conversion Prices Also Affected
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
today announced that, effective September 24, 2012, it has reduced the
exercise pric...
|
|
EpiCept Announces Changes to Its Board of Directors
Aug 30, 2012
|
12.8 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
announced today that A. Collier Smyth, Gerhard Waldheim and Wayne P.
Yetter have resigned from the Company's Board of Directors, effective
August 28, 2012. Their resigna...
|
|
EpiCept Announces Resignation of CEO Jack Talley
Aug 21, 2012
|
12.5 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
announced today that Jack Talley has resigned as President and CEO of
the Company and as a member of the Board of Directors effective August
20, 2012.
...
|
|
EpiCept Reports Second Quarter 2012 Operating and Financial Results
Aug 8, 2012
|
36.9 KB |
|
| |
CONFERENCE CALL BEGINS AT 9:00 A.M. EASTERN TIME TODAY
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
today reported net income of $3.0 million for the three months ended
June 30, 2012 and a red...
|
|
EpiCept to Report Second Quarter 2012 Operating and Financial Results on August 8, 2012
Aug 2, 2012
|
12.7 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
announced today that it will host a conference call to discuss second
quarter 2012 operating and financial results on Wednesday, August 8,
2012 at 9:00 a.m. Eastern time...
|
|
EpiCept Transfers Ceplene Responsibilities in European Union and Sells License Rights to Meda
Jun 19, 2012
|
13.5 KB |
|
| |
ONLY TERRITORY ALREADY LICENSED TO MEDA AFFECTED
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
today announced that it has sold all of its rights to Ceplene® in the
territories previously ...
|
|
EpiCept Corporation to Present at 2012 BIO International Convention
Jun 12, 2012
|
11.0 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
announced today that Jack Talley, President and Chief Executive Officer,
will be presenting at the 2012 BIO International Convention on
Wednesday, June 20, 2012 at 10:00...
|
|
EpiCept Corporation Receives Scientific Advice from European Medicines Agency for AmiKet™ CIPN Program
Jun 4, 2012
|
13.8 KB |
|
| |
Requirements Are Consistent with FDA Guidance
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
today announced that it has received formal scientific advice from the
Committee for Medicinal Produc...
|
|
EpiCept Reports First Quarter 2012 Operating and Financial Results
May 9, 2012
|
31.8 KB |
|
| |
CONFERENCE CALL BEGINS AT 9:00 A.M. EASTERN TIME TODAY
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
today announced operating and financial results for the three months
ended March 31, 201...
|
|
EpiCept to Report First Quarter 2012 Operating and Financial Results on May 9, 2012
May 3, 2012
|
11.9 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
announced today that it will host a conference call to discuss first
quarter 2012 operating and financial results on Wednesday, May 9, 2012
at 9:00 a.m. Eastern time. Th...
|
|
EpiCept's AmiKet™ Receives Fast Track Designation from FDA
Apr 10, 2012
|
12.2 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
announced today that AmiKet™ (amitriptyline 4%, ketamine 2% cream) has
been granted Fast Track designation by the U.S. Food and Drug
Administration (FDA). AmiKet&#...
|
|
EpiCept's Licensed Compound EP1013 Identified as a New Drug Candidate for Treatment of Late-Stage Viral Hepatitis
Apr 4, 2012
|
12.7 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
announced today that new preclinical research for its apoptosis
inhibitor drug candidate EP1013 (now renamed F573) has concluded that
F573 is a new therapeutic drug cand...
|
|
EpiCept to Raise $1.1 Million in Registered Direct Offering
Mar 29, 2012
|
12.6 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
announced today that it has entered into a definitive agreement with a
single life science focused institutional investor for the purchase of
1,065 shares of its new Ser...
|
|
EpiCept Corporation to Present at the BIO-Europe Spring 2012 Event
Mar 14, 2012
|
12.1 KB |
|
| |
TARRYTOWN, N.Y.--(BUSINESS WIRE)--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
announced today that Jack Talley, President and Chief Executive Officer,
will be presenting at the BIO-Europe Spring 2012 event on Tuesday, March
20, 2012 at 10:15 A...
|
|
|
